Researchers have sought to understand what motivates and prevents farmers from adopting selective clinical mastitis protocols. By helping dairy farmers and veterinarians navigate the identified barriers and by providing support, we can better position the dairy industry to achieve long-term improvement of antimicrobial stewardship practices on dairy farms.

When mastitis happens, it is easy to assume antibiotics are the next step. In many cases, they are, but not always. That’s where intentional mastitis treatment decisions make a difference.

We often hear that mastitis costs the U.S. dairy industry $2 billion per year. But what does this mean on a case level?

Managing herd health and reproduction on a dairy farm is a constant challenge that requires keen observation, experience and timely interventions. For Calori-D Dairy, implementing the CowManager monitoring system in December 2022 marked a turning point in how they managed their cows – both for health and reproduction.

Because control strategies differ depending on the type of mastitis, knowing the cause of infections in your herd is essential for targeted prevention and treatment.

Ever since 1894, Minglewood Dairy has upheld a tradition of exceptional care for their cows and land, evolving significantly over the past 130 years.

Knowing the classification of a mastitis case can help you choose which animals to treat, saving you money and improving judicious antibiotic use.

As dairy producers improve their management practices and the milk yield of their herds, mastitis will always be a threat to cows. Before jumping to antibiotic therapy, it is beneficial to provide an anti-inflammatory and pain relief.

When it comes to the topic of contagious mastitis in dairy cows, the conversation usually revolves around the well-known pathogens Staphylococcus aureus and mycoplasma, with the occasional nod to Streptococcus agalactiae.

Imagine a world without mastitis. It’s easy if you try. No costly treatments or increased risk of mortality, no reduced milk yields, no $2 billion economic loss in the industry.